Skip to main content
OpenTrials
Completed

NCT Number: NCT00489580

A Pilot Study Investigating the Feasibility of the Saebo Arm Training Program on an Inpatient Population

Study Objectives:

1. To document the safe and effective application of the F.T.M. Arm Training Program using the SaeboFlex to an inpatient post stroke rehabilitation population. 2. To compare functional improvements in hand and UE use achieved with the F.T.M. program as compared to generally applied therapeutic treatment approaches. 3. To develop recommendations for an inpatient retraining protocol that could then be evaluated in a multi-center trial. 4. To document the retention of UE and hand improvements after SaeboFlex training is discontinued as well as the carry over of these gains into daily function after therapy has been discontinued.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kessler Institute for Rehabilitation

East Orange, New Jersey, 07018, United States

About this study

Therapeutic interventions for the recovery of hand function after a neurological injury have historically been very limited. A significant body of research now supports the use of an upper extremity retraining approach for functional recovery after neurological injury. Few therapeutic approaches offer any intervention specifically focused on grasp and release retraining. In an effort to address this deficit, the SaeboFlex dynamic hand orthosis was developed by occupational therapists. The F.T.M. Arm Training Program has been safely used by hundreds of occupational and physical therapists on over one thousand patients in outpatient neurological rehabilitation over the past two years. It is currently an accepted modality of treatment for the management of hand paresis in the acquired brain injury population. During that time, two factors, other than the severity of the initial injury, were identified as having a significant affect on the outcomes achieved in treatment. They are learned non-use and soft tissue shortening of the finger flexors. All treatment delivered to the subjects that partake in this study will be clinical care and the only research component of this study will be the assessment of outcomes. The purpose of this study is to explore the proper treatment dosage and treatment protocol for the application of the F.T.M. Program to the inpatient post stroke rehabilitation population. Additionally, information on functional outcome measures will be collected and compared to a matched control group that undergoes the standard therapeutic protocol.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older,
  • Must be seen within three full working days of admission for screening
  • Alert and Oriented to person and place with the ability to complete at a minimum a one step verbal command,
  • Demonstrated active range of motion of 10 degrees shoulder flexion / abduction and 10 degrees of elbow flexion / extension
  • 1/4 range of volitional finger flexion when the affected hand is passively positioned in a minimum of 15degrees of wrist extension with the MCP's at neutral and PIP's / DIP's in extension
  • Patient must be independent with seated posture in a chair with a firm seat and back support but no arm rests
  • Patient can maintain independent seated balance when unaffected upper extremity is fully outstretched in any direction
  • Admitted to inpatient stroke rehabilitation at Kessler Institute

Exclusion criteria

  • Inpatient physician unwilling to clear patient to participate
  • Medically unsuitable for therapeutic intervention,
  • Using the affected hand and arm, able to volitionally grasp and release a racquet ball x10 at maximal volitional shoulder flexion with wrist extension of 10 degrees or more.
  • Flaccidity in the affected UE or hand
  • Fixed joint deformities, contractures or joint hypermobility that prevents proper joint positioning in the orthosis.
  • Hx of rheumatoid arthritis, carpal tunnel syndrome or other hand neuropathy
  • Moderate to severe weeping or pitting edema
  • No previous stroke prior to the one prompting admission

Treatment and study plan

SaeboFlex Dynamic Hand Orthosis

Device

Saebo F.T.M. Arm Training Program

Procedure

Primary outcomes

  1. Hand grip strength (measured using dynamometry)

    Time frame: At admission and at discharge

Secondary outcomes

  1. Length of Stay (days)

    Time frame: The duration of the subject's inpatient hospital stay.

  2. Stroke Impact Scale Score

    Time frame: At admission and at discharge

  3. Action Research Arm Test Score

    Time frame: At admission and at discharge

  4. Ashworth Assessment (Upper Extremity) Scores

    Time frame: At admission and at discharge

  5. Fugl-Meyer Assessment (Upper Extremity) Scores

    Time frame: At admission and at discharge

  6. Goniometric Range of Motion Evaluation, Passive and Active (Shoulder, Elbow, and Wrist)

    Time frame: At admission and at discharge

  7. Assessment of Active Range of Motion (Fingers, as ¼ range, ½ range, ¾ range or full range)

    Time frame: At admission and at discharge

Sponsors and collaborators

Lead sponsor

Kessler Foundation

Other

Collaborators

  • Saebo, Inc.

Registry information

Official study title

A Pilot Study Investigating the Feasibility of Using a Functional Tone Management (F.T.M.) Arm Training Program With the SaeboFlex Dynamic Hand Orthosis on an Inpatient Population

Important dates

Study start
2005
Study completion
2006
First posted
Jun 21, 2007
Registry last updated
Jul 25, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.